vs
Side-by-side financial comparison of IRONWOOD PHARMACEUTICALS INC (IRWD) and Lifevantage Corp (LFVN). Click either name above to swap in a different company.
Lifevantage Corp is the larger business by last-quarter revenue ($48.9M vs $47.7M, roughly 1.0× IRONWOOD PHARMACEUTICALS INC). Lifevantage Corp runs the higher net margin — 0.6% vs -4.8%, a 5.3% gap on every dollar of revenue. On growth, Lifevantage Corp posted the faster year-over-year revenue change (-27.8% vs -47.3%). IRONWOOD PHARMACEUTICALS INC produced more free cash flow last quarter ($74.6M vs $1.7M). Over the past eight quarters, Lifevantage Corp's revenue compounded faster (0.7% CAGR vs -20.2%).
Ironwood Pharmaceuticals, Inc. is a publicly traded pharmaceutical company. It was originally called Microbia, Inc.
Lifevantage Corp is a health and wellness enterprise that develops, manufactures and distributes science-backed nutritional supplements, skincare and personal care products. It operates via a direct-to-consumer network marketing model, serving customers across North America, Europe and the Asia-Pacific, with focus on anti-aging and holistic health solution segments.
IRWD vs LFVN — Head-to-Head
Income Statement — Q4 FY2025 vs Q2 FY2026
| Metric | | |
|---|---|---|
| Revenue | $47.7M | $48.9M |
| Net Profit | $-2.3M | $276.0K |
| Gross Margin | — | 74.0% |
| Operating Margin | 14.3% | 1.0% |
| Net Margin | -4.8% | 0.6% |
| Revenue YoY | -47.3% | -27.8% |
| Net Profit YoY | -200.9% | -89.2% |
| EPS (diluted) | $0.01 | $0.02 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $47.7M | $48.9M | ||
| Q3 25 | $122.1M | $47.6M | ||
| Q2 25 | $85.2M | $55.1M | ||
| Q1 25 | $41.1M | $58.4M | ||
| Q4 24 | $90.5M | $67.8M | ||
| Q3 24 | $91.6M | $47.2M | ||
| Q2 24 | $94.4M | $48.9M | ||
| Q1 24 | $74.9M | $48.2M |
| Q4 25 | $-2.3M | $276.0K | ||
| Q3 25 | $40.1M | $2.2M | ||
| Q2 25 | $23.6M | $2.0M | ||
| Q1 25 | $-37.4M | $3.5M | ||
| Q4 24 | $2.3M | $2.5M | ||
| Q3 24 | $3.6M | $1.8M | ||
| Q2 24 | $-860.0K | $1.3M | ||
| Q1 24 | $-4.2M | $1.7M |
| Q4 25 | — | 74.0% | ||
| Q3 25 | — | 79.5% | ||
| Q2 25 | — | 79.9% | ||
| Q1 25 | — | 81.0% | ||
| Q4 24 | — | 80.5% | ||
| Q3 24 | — | 79.9% | ||
| Q2 24 | — | 79.5% | ||
| Q1 24 | — | 78.9% |
| Q4 25 | 14.3% | 1.0% | ||
| Q3 25 | 61.8% | 4.8% | ||
| Q2 25 | 53.2% | 3.9% | ||
| Q1 25 | -70.7% | 6.9% | ||
| Q4 24 | 34.8% | 5.1% | ||
| Q3 24 | 28.0% | 5.4% | ||
| Q2 24 | 26.5% | 5.9% | ||
| Q1 24 | 14.7% | 4.0% |
| Q4 25 | -4.8% | 0.6% | ||
| Q3 25 | 32.8% | 4.5% | ||
| Q2 25 | 27.7% | 3.6% | ||
| Q1 25 | -90.9% | 5.9% | ||
| Q4 24 | 2.5% | 3.8% | ||
| Q3 24 | 4.0% | 3.9% | ||
| Q2 24 | -0.9% | 2.7% | ||
| Q1 24 | -5.6% | 3.4% |
| Q4 25 | $0.01 | $0.02 | ||
| Q3 25 | $0.23 | $0.17 | ||
| Q2 25 | $0.14 | $0.16 | ||
| Q1 25 | $-0.23 | $0.26 | ||
| Q4 24 | $0.03 | $0.19 | ||
| Q3 24 | $0.02 | $0.14 | ||
| Q2 24 | $-0.01 | $0.10 | ||
| Q1 24 | $-0.03 | $0.13 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $215.5M | — |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $-261.8M | $33.0M |
| Total Assets | $396.9M | $61.2M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $215.5M | — | ||
| Q3 25 | $140.4M | — | ||
| Q2 25 | $92.9M | $20.2M | ||
| Q1 25 | $108.5M | — | ||
| Q4 24 | $88.6M | — | ||
| Q3 24 | $88.2M | — | ||
| Q2 24 | $105.5M | $16.9M | ||
| Q1 24 | $121.5M | — |
| Q4 25 | — | — | ||
| Q3 25 | $199.5M | — | ||
| Q2 25 | $199.3M | — | ||
| Q1 25 | $199.2M | — | ||
| Q4 24 | $199.0M | — | ||
| Q3 24 | $198.8M | — | ||
| Q2 24 | $198.6M | — | ||
| Q1 24 | $398.3M | — |
| Q4 25 | $-261.8M | $33.0M | ||
| Q3 25 | $-264.2M | $33.2M | ||
| Q2 25 | $-308.2M | $34.6M | ||
| Q1 25 | $-334.1M | $34.0M | ||
| Q4 24 | $-301.3M | $29.9M | ||
| Q3 24 | $-311.3M | $27.7M | ||
| Q2 24 | $-321.7M | $26.0M | ||
| Q1 24 | $-330.5M | $26.8M |
| Q4 25 | $396.9M | $61.2M | ||
| Q3 25 | $396.1M | $61.6M | ||
| Q2 25 | $342.9M | $72.0M | ||
| Q1 25 | $327.2M | $77.2M | ||
| Q4 24 | $350.9M | $68.5M | ||
| Q3 24 | $389.5M | $61.5M | ||
| Q2 24 | $395.6M | $60.3M | ||
| Q1 24 | $438.8M | $61.3M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $74.6M | $2.8M |
| Free Cash FlowOCF − Capex | $74.6M | $1.7M |
| FCF MarginFCF / Revenue | 156.3% | 3.5% |
| Capex IntensityCapex / Revenue | 0.0% | 2.2% |
| Cash ConversionOCF / Net Profit | — | 10.11× |
| TTM Free Cash FlowTrailing 4 quarters | $127.0M | $1.7M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $74.6M | $2.8M | ||
| Q3 25 | $47.6M | $-2.3M | ||
| Q2 25 | $-15.1M | $1.0M | ||
| Q1 25 | $20.0M | $2.2M | ||
| Q4 24 | $15.2M | $9.2M | ||
| Q3 24 | $9.9M | $-583.0K | ||
| Q2 24 | $33.5M | $2.6M | ||
| Q1 24 | $45.0M | $3.1M |
| Q4 25 | $74.6M | $1.7M | ||
| Q3 25 | $47.6M | $-2.7M | ||
| Q2 25 | $-15.1M | $835.0K | ||
| Q1 25 | $19.9M | $1.9M | ||
| Q4 24 | — | $8.7M | ||
| Q3 24 | $9.9M | $-932.0K | ||
| Q2 24 | $33.4M | $2.3M | ||
| Q1 24 | $44.9M | $2.8M |
| Q4 25 | 156.3% | 3.5% | ||
| Q3 25 | 39.0% | -5.8% | ||
| Q2 25 | -17.7% | 1.5% | ||
| Q1 25 | 48.4% | 3.2% | ||
| Q4 24 | — | 12.8% | ||
| Q3 24 | 10.8% | -2.0% | ||
| Q2 24 | 35.4% | 4.7% | ||
| Q1 24 | 60.0% | 5.8% |
| Q4 25 | 0.0% | 2.2% | ||
| Q3 25 | 0.0% | 0.9% | ||
| Q2 25 | 0.0% | 0.4% | ||
| Q1 25 | 0.1% | 0.6% | ||
| Q4 24 | 0.0% | 0.7% | ||
| Q3 24 | 0.0% | 0.7% | ||
| Q2 24 | 0.1% | 0.6% | ||
| Q1 24 | 0.1% | 0.6% |
| Q4 25 | — | 10.11× | ||
| Q3 25 | 1.19× | -1.07× | ||
| Q2 25 | -0.64× | 0.53× | ||
| Q1 25 | — | 0.64× | ||
| Q4 24 | 6.74× | 3.61× | ||
| Q3 24 | 2.71× | -0.32× | ||
| Q2 24 | — | 1.98× | ||
| Q1 24 | — | 1.86× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
